Schiehallion Fund Limited (MNTN) ORD NPV
Sell:$0.89
Buy:$0.93
0
Change:
$0.02
(2.15%)
$0.02
(2.15%)
Market closed |
Prices as at close on 22 November 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
- Add to watchlist
- This stock can be held in a
Sell:$0.89
Buy:$0.93
Change:
$0.02
(2.15%)
$0.02
(2.15%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Market closed |
Prices as at close on 22 November 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
Sell:$0.89
Buy:$0.93
Change:
$0.02
(2.15%)
$0.02
(2.15%)
Market closed |
Prices as at close on 22 November 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Objective
To generate capital growth for investors through making long-term minority investments in later stage private businesses that the Company considers to have transformational growth potential and to have the potential to become publicly traded. Those investments will typically take the form of equity or equity-related instruments (which may include, without limitation, preference shares, convertible debt instruments, equity-related and equity-linked notes and warrants) issued by Investee Companies.
| Security | Weight |
|---|---|
| Bending Spoons S.P.A. Class C | 5.65% |
| Space Exploration Technologies Corp Series K Pref. | 4.49% |
| Wise plc ORD GBP0.01 | 4.43% |
| Affirm Holdings Inc Ordinary Shares - Class A | 4.33% |
| Bytedance Ltd Series E-1 Pref. | 4.25% |
| Tempus AI Inc Class A common stock | 3.73% |
| Space Exploration Technologies Corp Series N Pref. | 3.39% |
| Bytedance Ltd Series E Pref. | 3.14% |
| Brex Inc. Class B Common | 2.96% |
| Wayve Technologies Ltd Series B Pref. | 2.93% |
| Sector | Weight |
|---|---|
| Technology | 10.30% |
| Healthcare | 6.88% |
| Country | Weight |
|---|---|
| United States | 18.67% |
| United Kingdom | 4.43% |
| Israel | 1.54% |
| Sweden | 0.02% |
Fee Structure
The Manager will be entitled to a fee payable quarterly in arrears a on the NAV up to and including USD 650m, at a rate of 0.9% b exceeding USD 650m up to and including USD 1.3bn, at a rate of 0.8% and c exceeding USD 1.3bn, at a rate of 0.7%. No performance fee. The Agreement may be terminated on the notice of six months.
Dividend Policy
The Company's priority is to generate capital growth over the long term. The Company therefore has no dividend target and will not seek to provide shareholders with a particular level of distribution.
ASSET SPLIT
Trust Manager
Peter Singlehurst
Manager Bio
Not currently available for this investment trust.
Board Of Directors
Linda YuehChairman, Richard Holmes, John Mackie, Trudi Clark
Data policy - All information should be used for indicative purposes only. You should
independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete,
and accepts no responsibility for how it may be used.
Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.